Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Seung-Jung Park

Status: Enrolling

Conditions: Coronary Artery Disease

Study type: Observational

Funder types: Other

Identifiers

NCT01788592

AMCCV2013-02

Details and patient eligibility

About

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Enrollment: 50,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• coronary disease amenable to percutaneous coronary intervention (PCI)
• no clinical and lesion limitations

Exclusion criteria

• patients with a mixture of several drug eluting stents
• terminal illness with life expectancy less than 1 year
• patients with cardiogenic shock

Trial design

50,000 participants in 1 patient group

Drug eluting stent

Description:

Patients who receiving drug eluting stents